chloroquine has been researched along with Herpes Zoster in 4 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Herpes Zoster: An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with rheumatoid arthritis (RA) are at increased risk of herpes zoster (HZ), and the risk appears to be increased in patients treated with tofacitinib." | 7.85 | Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy. ( Bananis, E; Chen, C; Curtis, JR; Fan, H; Hirose, T; Lindsey, S; Mendelsohn, AM; Nduaka, CI; Tanaka, Y; Valdez, H; Wang, L; Winthrop, KL; Yamaoka, K, 2017) |
| "These data suggest that chloroquine diphosphate could predispose patients with dermatomyositis/polymyositis to developing herpes zoster, particularly women and dermatomyositis patients." | 7.79 | Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis. ( Cunha, GF; Levy-Neto, M; Shinjo, SK; Souza, FH, 2013) |
| "Patients with rheumatoid arthritis (RA) are at increased risk of herpes zoster (HZ), and the risk appears to be increased in patients treated with tofacitinib." | 3.85 | Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy. ( Bananis, E; Chen, C; Curtis, JR; Fan, H; Hirose, T; Lindsey, S; Mendelsohn, AM; Nduaka, CI; Tanaka, Y; Valdez, H; Wang, L; Winthrop, KL; Yamaoka, K, 2017) |
| "These data suggest that chloroquine diphosphate could predispose patients with dermatomyositis/polymyositis to developing herpes zoster, particularly women and dermatomyositis patients." | 3.79 | Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis. ( Cunha, GF; Levy-Neto, M; Shinjo, SK; Souza, FH, 2013) |
| " Six Papua New Guinean children under 9 years of age developed herpes zoster following an episode of malaria, due to Plasmodium falciparum or Plasmodium vivax which was treated with chloroquine." | 3.67 | Herpes zoster in children following malaria. ( Cook, IF, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Winthrop, KL | 1 |
| Curtis, JR | 1 |
| Lindsey, S | 1 |
| Tanaka, Y | 1 |
| Yamaoka, K | 1 |
| Valdez, H | 1 |
| Hirose, T | 1 |
| Nduaka, CI | 1 |
| Wang, L | 1 |
| Mendelsohn, AM | 1 |
| Fan, H | 1 |
| Chen, C | 1 |
| Bananis, E | 1 |
| Cunha, GF | 1 |
| Souza, FH | 1 |
| Levy-Neto, M | 1 |
| Shinjo, SK | 1 |
| Turno-Kręcicka, A | 1 |
| Tomczyk-Socha, M | 1 |
| Zimny, A | 1 |
| Cook, IF | 1 |
4 other studies available for chloroquine and Herpes Zoster
| Article | Year |
|---|---|
Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Clinical Trials as Topic; Dat | 2017 |
Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Chloroquine; Dermatomyositis; | 2013 |
Progressive outer retinal necrosis syndrome in the course of systemic lupus erythematosus.
Topics: Adult; Antiviral Agents; Central Nervous System Neoplasms; Chloroquine; Chorioretinitis; Fatal Outco | 2016 |
Herpes zoster in children following malaria.
Topics: Child; Child, Preschool; Chloroquine; Female; Herpes Zoster; Humans; Immune Tolerance; Immunity, Cel | 1985 |